Lindenwold Advisors Medpace Holdings, Inc. Transaction History
Lindenwold Advisors
- $187 Million
- Q2 2024
A detailed history of Lindenwold Advisors transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Lindenwold Advisors holds 1,994 shares of MEDP stock, worth $714,390. This represents 0.44% of its overall portfolio holdings.
Number of Shares
1,994
Previous 2,046
2.54%
Holding current value
$714,390
Previous $826,000
0.61%
% of portfolio
0.44%
Previous 0.44%
Shares
11 transactions
Others Institutions Holding MEDP
# of Institutions
632Shares Held
25.1MCall Options Held
38.7KPut Options Held
64.7K-
Black Rock Inc. New York, NY2.58MShares$924 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$906 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT967KShares$347 Million2.15% of portfolio
-
Invesco Ltd. Atlanta, GA807KShares$289 Million0.07% of portfolio
-
State Street Corp Boston, MA703KShares$252 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $11.1B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...